Omeros prices transplant complication drug at $36,000 per dose

Core Viewpoint - Omeros has set the price for its newly approved drug, aimed at treating a life-threatening transplant complication, at $36,000 per single-dose vial, as stated by CEO Gregory Demopulos during an analyst call [1] Company Summary - The drug is approved for use in both adults and children aged two and older [1]